Clinical Trial Update: Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA) [Phase 4]

View source ↗

Summary

A Phase 4 trial studying switching between anti-TNF-alpha therapies for rheumatoid arthritis was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED | Results posted: 2012-08-13